Andrew Moran

Associate Professor

Columbia University Irving Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrew Moran is an Associate Professor at Columbia University Medical Center in the United States. His research focuses on hypertension treatment, medication adherence, and cost-effectiveness in cardiovascular care, as evidenced by his recent publications. Dr. Moran has contributed to understanding global hypertension control and the integration of cardiovascular and metabolic care in primary health settings.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

James Sheppard

University of Oxford

UNITED KINGDOM

View details

William Weintraub

UNITED STATES

View details

Mark Huffman

Professor and Co-Director, Global Health Center

Washington University in St. Louis

UNITED STATES

UNITED STATES

View details

Catherine Derington

Research Assistant Professor

University of Utah

UNITED STATES

View details

Daichi Shimbo

Columbia University Irving Medical Center

UNITED STATES

View details

Norrina Allen

Associate Professor, Tenured

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Moran

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Association Between Fixed-Dose Combination Use and Medication Adherence, Health Care Utilization, and Costs Among Medicaid Beneficiaries

Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association Guidelines

Calcium Channel Blockers: Key Medicine to Drive Global Hypertension Control

Priorities for Research on Hypertension Care Delivery: A WHO Report Executive Summary

Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1

Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction

Effectiveness of Hypertension Management Strategies in SPRINT‐Eligible US Adults: A Simulation Study

Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown

Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment–Related Complication Hospitalizations in the United States

Integrated Antihypertensive and Statin Treatment Protocols for Cardiovascular Disease Prevention in Low- and Middle-Income Countries

Effectiveness and Cost-Effectiveness of Team-Based Care for Hypertension: A Meta-Analysis and Simulation Study

Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial

Cost-effectiveness analysis of initial treatment with single-pill combination antihypertensive medications

Fixed‐Dose Combination Medication Use Among US Adults With Hypertension: A Missed Opportunity

Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations

Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations

HEARTS in the Americas: a global example of using clinically validated automated blood pressure devices in cardiovascular disease prevention and management in primary health care settings

Collaborators (12)

James Sheppard

William Weintraub

Mark Huffman

Jordan B. King

Anthony Rodgers

Kelsey Bryant

Adam Bress

Ian Kronish

Brandon K. Bellows

Catherine Derington

Daichi Shimbo

Norrina Allen

Make your next move.